VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:
- Biotechnology
- Chemicals
- Food processing
- Electronics
- Healthcare
- Pharmaceuticals
Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:
- Market segmentation
- Competitive landscape
- Regulatory policies
- Latest technology trends
- Acquisition evaluations
- Vendors’ analysis, etc.
Publications found:
60,074
Sort by:
2017 New Zealand Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the ... spectroscopy. Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments of major ...
January 2017
535 pages
2017 United Arab Emirates Cancer Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... others. Instrumentation Review Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling ... . Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Assessments Strategic assessments ...
January 2017
535 pages
2017 Argentina Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Bahrain Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Kuwait Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Qatar Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
January 2017
535 pages
2017 Argentina Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Argentina diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
2017 Bahrain Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Bahrain diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
2017 Bangladesh Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Bangladesh diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
2017 Brazil Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Brazil diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
2017 Chile Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
US$ 4,050.00
... provides granular analysis of the Chile diagnostic testing market, including volume and sales forecasts by test for the following market segments: Blood Banking Cancer Chemistry Coagulation Drugs of Abuse Endocrine Hematology and Flow Cytometry Immunoprotein Infectious Diseases Molecular Diagnostics ...
January 2017
40 pages
